Navigation Links
Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
Date:8/8/2011

ALISO VIEJO, Calif., Aug. 8, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Dr. Joao Siffert to the position of senior vice president research and development. In this newly created role, Dr. Siffert will be responsible for leading all of the company's research and development activities.

"We are thrilled to have another leader of Joao's caliber join the Avanir team," said Keith A. Katkin, president and CEO of Avanir. "His depth of medical knowledge and experience in developing novel neurologic therapeutics will be essential as we look to expand our pipeline. Joao will help propel our initiatives through both follow-on indications of NUEDEXTA and the potential in-licensing of further products to treat central nervous system disorders of high unmet need."

Dr. Siffert previously served as vice president and chief medical officer at Ceregene, Inc., a biotechnology company focused on the development of neurotrophic gene therapies for Alzheimer's and Parkinson's diseases. Prior to this position he served as the chief medical officer at Avera Pharmaceuticals, a CNS specialty pharma company. Prior to joining Avera, Dr. Siffert held positions with Pfizer as the worldwide medical team leader of Lyrica and Neurontin focusing in areas of pain and epilepsy and as medical director for Relpax. He was instrumental in the Phase 3b/4 program development and global launch of Lyrica. Prior to Pfizer, Dr. Siffert held academic positions at Beth Israel Medical Center, where he served as director of the Adult Neuro-Oncology program, and Albert Einstein College of Medicine, where he was assistant professor of neurology. During his tenure at Beth Israel, Dr. Siffert was actively involved in clinical research of novel therapies for patients with brain and spinal cord tumors. He completed residencies in pediatrics at New York Universit
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
2. Avanir Pharmaceuticals Provides Update on European Regulatory Filing for NUEDEXTA
3. Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
4. Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results
5. Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
6. Avanir Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
7. Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
8. Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting
9. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... INDIANAPOLIS , May 29, 2015  Eli Lilly ... AZN ) today announced that they have entered ... and preliminary efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint ... Lilly,s VEGF Receptor 2 antiangiogenic cancer medicine. The planned ... patients with advanced solid tumors. The Phase ...
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... VANCOUVER and HOUSTON , May ... "Company") (TSX-V: EPI) today reported financial results for the second ... Amounts, unless specified otherwise, are expressed in Canadian dollars and ... Summary Results ESSA recorded a net ... six months ended March 31, 2015 (Q2-2015), compared to a ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... SynCo Bio Partners B.V., a leading,GMP biopharmaceutical ... Pharmaceuticals, a company developing novel therapeutics that,target cancer ... and finish,batches of OncoMed,s lead product, antibody OMP-21M18, ... the agreement, Pierre Warffemius, CEO, said, "We are,delighted ...
... Inc. ("Senesco" or the "Company") (Amex: SNT ... preclinical pancreatic islet,cell research that was funded by ... Senesco,s Factor 5A technology, the data show what ... regarding delivery of the,technology as well as islet ...
Cached Medicine Technology:OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody 2Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data 2Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data 3
(Date:5/29/2015)... PALMER LAKE, CO (PRWEB) May 29, 2015 ... a brand new addiction, substance abuse, and co-occurring ... Opening celebration and ribbon cutting for the general ... patients June 2nd. , The Recovery Village at ... hospitalization, and intensive outpatient programming, utilizing traditional and ...
(Date:5/29/2015)... May 29, 2015 According to a recent ... 10 full-time workers has a substance abuse problem - the ... than 111,500 adults with full-time jobs, revealed that 9.5% of ... previous year. (1) The National Council on Alcoholism and Drug ... year, and an estimated 70% of the 14.8 million illicit ...
(Date:5/29/2015)... 29, 2015 Jan Wooden Howse lost her ... thing above all else: God does no wrong. , It’s ... her son’s passing is titled “God Does No Wrong.” It ... with great personal tragedy. , “My story has a ... to you into something productive, something healing,” Howse said. , ...
(Date:5/29/2015)... RIDGELAND, Miss. (PRWEB) May 29, 2015 ... recently announced the graduates of its Advanced Training ... trains students, who fill roles in their health ... both the theory and methodology of continuous quality ... is a sister-program to Dr. Brent James’ internationally ...
(Date:5/29/2015)... 2015 Intermountain Healthcare of ... Stratus Video Interpreting for on-demand ... communication and timely care for patients with ... Stratus’ video remote interpreting (VRI) services will ... to quickly access qualified medical interpretation in ...
Breaking Medicine News(10 mins):Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Turning grief from a child’s passing into virtue 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4
... new research, conducted at UCL (University College London) thatis ... tight situation results// in irrational behaviour. The ability to ... result in rational behaviour. ,The classical theories ... a decision. But it is not the case always. ...
... and customers who came to the Brampton, Ont., Tim Horton's ... hepatitis A.// ,According to health officials in Peel ... Intermodal Dr. has tested positive for hepatitis A. ... Villa, has assured that the risk of transmission is low. ...
... the University of Bern in Switzerland, AIDS drugs are ... due the drug. ,There is also decreased ... ten years since the antiretroviral (ARVs) have been introduced ... Scientists say that the combinations of drugs reduce mortality ...
... discovered that fibrin fibers could stretch to three times its ... could even stretch to six times// their original length before ... in the blood from a soluble protein, fibrinogen. When ... the form of a mesh, which dries and hardens, so ...
... over a particular brand of milk, Anlene, which could cause ... Fonterra, the company// that is manufacturing the brand of milk ... the impending risks of the milk on consumers taking the ... on the product. ,Vitamin K, one of ...
... Orissa, who was denied admission to a medical college here ... percent disability, has urged President// A.P.J. Abdul Kalam to intervene. ... category of the state joint entrance examination, was denied admission ... on examining her again despite the chief district medical officer ...
Cached Medicine News:Health News:"Active" Brain Makes Rational Decisions!! 2
... The ReSeeVit 3Z slit lamp is designed ... This video ready slit lamp offers the ... another addition to the ReSeeVit family of ... on the market to capture clear, crisp ...
... system combines continuous access, random ... a broad testing menu. AxSYM ... clinical laboratories to process a ... as well as adding tests ...
... VIDAS is an automated, multiparametric ... testing device stores the calibration ... optimizing the cost-per-patient result. ... uni/bi-directional interface, labor cost is ...
... The AIA-1800 is the newest and ... Bioscience, Inc. The AIA-1800 launches with ... including tumor markers, thyroid, reproductive, cardiac, and ... per hour throughput, bar-coded primary tube sampling, ...
Medicine Products: